Efficacy and motor complications of original and generic levodopa in Parkinson's disease treatment

QR Code

Efficacy and motor complications of original and generic levodopa in Parkinson's disease treatment

Narongrit Kasemsap,1 Satrirat Onsanit,2 Piyawan Chiewthanakul,3 Kannikar Kongbunkiat,1 Chonthicha Tanking,1 Nisa Vorasoot,1 Kittisak Sawanyawisuth,1,4 Somsak Tiamkao1,5 1Department of Medicine, Faculty of Medicine, Khon Kaen University, Khon Kaen, 2Department of Medicine, Udonthani Hospital, Udonth...

Description complète

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Kasemsap N, Onsanit S, Chiewthanakul P, Kongbunkiat K, Tanking C, Vorasoot N, Sawanyawisuth K, Tiamkao S
Format:	article
Langue:	EN
Publié:	Dove Medical Press 2016
Sujets:	Parkinson’s disease original generic levodopa efficacy motor complication Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429
Accès en ligne:	https://doaj.org/article/1327f5ff3ec74af9b9aa276c0d383a7c
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Levodopa en la enfermedad de Parkinson: ¿Qué hemos aprendido?
par: Juri C,Carlos, et autres
Publié: (2006)

Comparación farmacocinética de Sinemetây Grifoparkinâ (levodopa/carbidopa 250/25 mg) en pacientes con enfermedad de Parkinson avanzada: un estudio con dosis única
par: Chaná C,Pedro, et autres
Publié: (2003)

Levodopa in the treatment of Parkinson’s disease: an old drug still going strong
par: Werner Poewe, et autres
Publié: (2010)

Profile Of Patients With Advanced Parkinson’s disease Suitable For Device-Aided Therapies: Restrospective Data Of A Large Cohort Of Romanian Patients
par: Szász JA, et autres
Publié: (2019)

Von Economo’s disease and postencephalitic parkinsonism responsive to carbidopa and levodopa
par: Bigman DY, et autres
Publié: (2018)

The Added Benefit of Opicapone When Used Early in Parkinson's Disease Patients With Levodopa-Induced Motor Fluctuations: A Post-hoc Analysis of BIPARK-I and -II
par: José-Francisco Rocha, et autres
Publié: (2021)

Síndrome neuroléptico maligno-like como complicación en enfermedad de Parkinson: Desenlace fatal. Reporte de un caso y revisión de la literatura
par: Salinas S,Carlos, et autres
Publié: (2014)

The abnormal activation of D1R/Shp-2 complex involved in levodopa-induced dyskinesia in 6-hydroxydopamine-lesioned Parkinson’s rats
par: Wu N, et autres
Publié: (2018)

Impact of intravenous thrombolysis on length of hospital stay in cases of acute ischemic stroke
par: Kasemsap N, et autres
Publié: (2018)

Consideraciones sobre las complicaciones motoras y neurotoxicidad de la levodopa en la enfermedad de Parkinson
par: Venegas F.,Pablo
Publié: (2005)

A comparison between Bromocriptine and Selegiline in treatment of Parkinsons disease
par: A Ahmadi Ahangar, et autres
Publié: (2002)

Relationships between Freezing of Gait Severity and Cognitive Deficits in Parkinson’s Disease
par: Jamie L. Scholl, et autres
Publié: (2021)

Tolcapone: review of its pharmacology and use as adjunctive therapy in patients with Parkinson's disease
par: Daniel D Truong
Publié: (2009)

Levodopa-Carbidopa Intestinal Gel Infusion Therapy Discontinuation: A Ten-Year Retrospective Analysis of 204 Treated Patients
par: Constantin VA, et autres
Publié: (2020)

Journal of generic medicines
Publié: (2003)

Therapeutic strategies in the early stages of Parkinson’s disease: a cross-sectional evaluation of 15 years’ experience with a large cohort of Romanian patients
par: Szász JA, et autres
Publié: (2019)

Correlation between Serum Zinc Levels and Levodopa in Parkinson’s Disease
par: Hirofumi Matsuyama, et autres
Publié: (2021)

Profile of inhaled levodopa and its potential in the treatment of Parkinson’s disease: evidence to date
par: Patel AB, et autres
Publié: (2018)

Parkinson's disease

GENERICITY AND THE INTERPRETATION OF THE COPULAS BY SPANISH-SPEAKING CHILDREN
par: HOLTHEUER BEAUSIRE,CAROLINA, et autres
Publié: (2015)

Onset and duration of effect of extended-release carbidopa-levodopa in advanced Parkinson’s disease
par: Hauser RA, et autres
Publié: (2018)

Role and clinical utility of pramipexole extended release in the treatment of early Parkinson's disease
par: Hametner EM, et autres
Publié: (2012)

Impact of Supporting People with Advanced Parkinson’s Disease on Carer’s Quality of Life and Burden
par: Modugno N, et autres
Publié: (2020)

DEVELOPMENT OF A MODIFIED CARBON ELECTRODE WITH IONIC LIQUID AND ITS APPLICATION FOR ELECTROCATALYTIC OXIDATION AND VOLTAMMETRIC DETERMINATION OF LEVODOPA
par: MONCADA,V, et autres
Publié: (2014)

Levodopa-Loaded 3D-Printed Poly (Lactic) Acid/Chitosan Neural Tissue Scaffold as a Promising Drug Delivery System for the Treatment of Parkinson’s Disease
par: Ezgi Saylam, et autres
Publié: (2021)

SOME ASPECTS OF EFFECTIVENESS AND SAFETY OF ANTIBACTERIAL DRUGS IN PREGNANCY
par: D. Y. Zhukova, et autres
Publié: (2012)

Generic Extensions in Contemporary British Poetry
par: Peter Hühn
Publié: (2021)

Transcranial Magnetic Stimulation Alleviates Levodopa-Induced Dyskinesia in Parkinson's Disease and the Related Mechanisms: A Mini-Review
par: Yi Wu, et autres
Publié: (2021)

Journal of Parkinson's disease

Effects and molecular mechanism of chitosan-coated levodopa nanoliposomes on behavior of dyskinesia rats
par: Cao,Xuebing, et autres
Publié: (2016)

Psychosocial therapy for Parkinson's-related dementia: intervention development
par: McCormick SA, et autres
Publié: (2017)

Assessment of cognitive impairment in patients with Parkinson's disease: prevalence and risk factors
par: Wang Q, et autres
Publié: (2014)

Factors associated with poor discharge status in patients with status epilepticus at Khon Kaen hospital
par: Chiewthanakul P, et autres
Publié: (2015)

Electrocatalytic determination of levodopa in presence of cabergoline using carbon paste electrode modified with graphene quantum dots/2-chlorobenzoyl ferrocene/ionic liquid
par: Peyman Mohammadzadeh Jahani
Publié: (2021)

Slurs: Semantic Content, Expressive Content and Social Generics
par: Federico Cella
Publié: (2017)

Terapia neuroprotectora de la Enfermedad de Parkinson
par: Miranda,Marcelo, et autres
Publié: (2004)

A posturographic procedure assessing balance disorders in Parkinson's disease: a systematic review
par: Kamieniarz A, et autres
Publié: (2018)

Pharmacological methods of therapy in Parkinson’s disease
par: Y. N. Bykov, et autres
Publié: (2016)

Ethical Acceptability of Using Generic Consent for Secondary Use of Data and Biological Samples in Medical Research
par: Frunză,Ana, et autres
Publié: (2017)

Microglial AGE-albumin is critical for neuronal death in Parkinson's disease: a possible implication for theranostics
par: Bayarsaikhan E, et autres
Publié: (2016)